Evidence map›Paper›PMID 42382122›Full record

ReviewThe Lancet regional health. Europe2026

Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness Agenda.

Marion Koopmans, Christian Brechot, Roberto Bruzzone, Moussa Moïse Diagne, Christian Drosten, Isabella Eckerle, Robert Gallo, David T S Hayman, Peter Horby, Peter Hotez and 16 more

Abstract readReview
In one paragraph

Review in The Lancet regional health. Europe, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Andes Virus: From Transmission Dynamics to Pandemic Potential.European journal of clinical investigation · 2026
    Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Marion KoopmansDirector Pandemic and Disaster Preparedness Research Center, and Viroscience Department, Erasmus MC, Rotterdam, the Netherlands.
Christian BrechotDepartment of Internal Medicine, University of South Florida, USA.
Roberto BruzzoneCenter for Immunology & Infection, Hong Kong Science Park, Hong Kong Special Administrative Region, PR China.
Moussa Moïse DiagneVirology Department, Institut Pasteur de Dakar, Senegal.
Christian DrostenInstitute of Virology, Charité Universitätsmedizin Berlin, Germany.
Isabella EckerleGeneva Centre for Emerging Viral Diseases, University Hospitals of Geneva and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Robert GalloDivision of Infectious Diseases, University of South Florida, USF Health Institute for Translational Virology & Innovation, Tampa General Hospital Cancer Institute, USA.
David T S HaymanMolecular Epidemiology and Public Health Laboratory, Massey University, New Zealand.
Peter HorbyPandemic Sciences Institute, Oxford University, Oxford, UK.
Peter HotezNational School of Tropical Medicine, Baylor College of Medicine, USA.
Menno de JongCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Florian KrammerIgnaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
Jean Claude ManuguerraInstitut Pasteur, Université Paris Cité, Environment and Infectious Risks Unit, Laboratory for Urgent Response to Biological Threats (CIBU), French National Reference Centre for Hantaviruses, France.
Gustavo PalaciosGlobal Health Emerging Pathogens Institute, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, United States.
Massimo PalmariniDepartment of Viroscience, Erasmus Medical Centre, Rotterdam, the Netherlands.
Anja SchreijerPandemic and Disaster Preparedness Research Center, Erasmus MC, Rotterdam, the Netherlands.
Nicole D TischlerLaboratorio de Virología Molecular, Centro Ciencia & Vida, Fundación Ciencia & Vida and Escuela de Bioquímica, Facultad de Ciencias, Universidad San Sebastián, Santiago, Chile.
Tulio de OliveiraCentre for Epidemic Response and Innovation (CERI), Stellenbosch University, Stellenbosch, South Africa.
Bas B Oude MunninkDepartment of Viroscience, Erasmus MC, Rotterdam, the Netherlands.
Malik PeirisSchool of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region, PR China.
Emma ThomsonMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Olli VapalahtiDepartments of Virology and Veterinary Biosciences, University of Helsinki, and Helsinki University Hospital Diagnostic Center, Finland.
Marietjie VenterFaculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Jacqueline WeyerCenter for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases, A Division of the National Health Laboratory Service, Johannesburg, South Africa.
Yazdan YazdanpanahInfectious Disease Department at Bichat-Claude Bernard Hospital, Director ANRS Emerging Infectious Diseases, Paris, France.
Erik A KarlssonVirology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of hantavirus disease caused by Andes virus aboard a cruise ship is a reminder of the challenges posed by emerging diseases in the modern era. While Andes virus-associated disease can be particularly severe, it is unlikely to spread extensively beyond the current number of cases or emerge as a large epidemic, especially if public health measures are followed. Nonetheless, the outbreak exemplifies the complexity of international outbreak response with differences in national preparedness frameworks and the rapid spread of mis-/disinformation. We discuss this outbreak in the context of global epidemic and pandemic preparedness and emphasize the importance of sustained, inclusive global collaborative One Health approaches to preparedness and response. We stress the urgent need for global coordination, discuss specific challenges, and provide recommendations for further strengthening of global preparedness.

Indexed as

HantavirusPandemic preparedness in a connected world

Identifiers

PMID42382122
PMCPMC13315895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.